Anti-Horse MHC Class II Monomorphic Antibody, clone CVS20 (FITC)
Mouse Anti-Horse Monoclonal Antibody
|Purification||Purified IgG prepared by affinity chromatography on Protein A from tissue culture supernatant|
|Shelf Life||12 months from date of reconstitution.|
|Target/Specificity||Mouse anti-Horse MHC Class II Monomorphic antibody, clone CVS20 recognizes monomorphic equine MHC Class II and was classified at the International Equine Leucocyte Antigen Workshop. Clone CVS20 reacts with all equine B cells and 95% of equine T cells.The major histocompatibility complex (MHC) is a cluster of genes that are important in the immune response to infections. In horses, this is referred to as the equine leukocyte antigen (ELA) region.|
|Preservative & Stabilisers||0.09% Sodium Azide (NaN3); 1% Bovine Serum Albumin|
|Storage||Store at +4℃ or -20℃.|
|Precautions||Anti-Horse MHC Class II Monomorphic Antibody, clone CVS20 (FITC) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
1. Kydd, J.H. & Antczak. D.F. (1991) Report of the First International Workshop on Equine Leucocyte Antigens, Cambridge, UK, July 1991Equine Immunol. 4: 5. 2. Lunn, D.P. et al. (1998) Report of the Second Equine Leucocyte Antigen Workshop, Squaw valley, California, July 1995. Vet. Immunol. Immunopathol. 62: 101-143. 3. Weiss, D. et al. (2001) Regulation of expression of major histocompatibility antigens by bovine macrophages infected with Mycobacterium avium subsp. paratuberculosis or Mycobacterium avium subsp. avium.Infect. Immun. 69 (2): 1002 - 1008. 4. Out, T. et al. (2002) Local T-cell activation after segmental allergen challenge in the lungs of allergic dogs. Immunology. 105: 499 - 508. 5. Carrade, D.D. et al. (2011) Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses.Cytotherapy. 13: 419-30. 6. Catchpole, B. et al. (2002) Generation of blood-derived dendritic cells in dogs with oral malignant melanoma.J Comp Pathol. 126: 238-41. 7. Weiss, D.J. et al. (2006) Mucosal immune response in cattle with subclinical Johne's disease.Vet Pathol. 43: 127-35. 8. Weiss, D.J. (2001) Evaluation of proliferative disorders in canine bone marrow by use of flow cytometric scatter plots and monoclonal antibodies.Vet Pathol. 38: 512-8. 9. Sassa, Y. et al. (2010) Bovine macrophage degradation of scrapie and BSE PrPScVet Immunol Immunopathol. 133: 33-9. 10. Carrade, D.D. et al. (2012) Comparative Analysis of the Immunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem Cells.Cell Medicine. 4: 1-11. 11. Bertone Alicia (2016) Cathepsin K inhibition renders equine bone marrow nucleated cells hypo-responsive to LPS and unmethylated CpG stimulation in vitroComparative Immunology, Microbiology and Infectious Diseases. Feb 27 [Epub ahead of print].1. Burk, J. et al. (2013) Equine cellular therapy-from stall to bench to bedside?Cytometry A. 83: 103-13
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.